Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
The complex effects of plant cannabinoids on human physiology is not yet fully understood, but include a wide spectrum of effects on immune modulation. The immune system and its inflammatory effector pathways are recently emerging as possible causative factors in psychotic disorders. The present stu...
Main Authors: | Attila Szabo, Ibrahim A. Akkouh, Thor Ueland, Trine Vik Lagerberg, Ingrid Dieset, Thomas Bjella, Pål Aukrust, Stephanie Le Hellard, Anne-Kristin Stavrum, Ingrid Melle, Ole A. Andreassen, Srdjan Djurovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyt.2020.00642/full |
Similar Items
-
Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
by: Elina J. Reponen, et al.
Published: (2020-07-01) -
Development and Validation of a Reporter-Cell-Line-Based Bioassay for Therapeutic Soluble gp130-Fc
by: Lei Yu, et al.
Published: (2019-10-01) -
Differences in white blood cell proportions between schizophrenia cases and controls are influenced by medication and variations in time of day
by: Jonelle D. Villar, et al.
Published: (2023-06-01) -
Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)
by: Dominik M. Schulte, et al.
Published: (2022-06-01) -
Increased levels of NT-proBNP and troponin T 2 years after coronary artery bypass grafting complicated by mediastinitis
by: Ivar Risnes, et al.
Published: (2023-02-01)